Class Action Attorney Juan Monteverde of Monteverde & Associates PC is leading an investigation into Kezar Life Sciences, Inc. regarding its proposed sale to Aurinia Pharmaceuticals Inc. Under the deal, shareholders would receive $6.955 per share in cash along with a contingent value right. The firm, located in the Empire State Building, is recognized as one of the top in its field, having recovered millions for shareholders. Interested parties can consult the firm for additional information without cost.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.prnewswire.com/news-releases/hareholder-alert-the-ma-class-action-firm-announces-an-investigation-of-kezar-life-sciences-inc-nasdaq-kzr-302728843.html
